CCN4 and Alzheimer disease: Increased expression of WISP1 during neuronal injury may have a significant correlation with enhanced cellular survival and WISP1 may serve as a therapeutic target against neurodegenerative disorders such as Parkinson's disease and Alzheimer's disease.